Effect of Kanashatahwadi Kashaya Orally and Asanadi Niruha Basti in management of Polycystic Ovarian Disease (PCOD)

Vaishali Mishra; Vishwesh B.N; Ankit Lakra

doi:10.21760/jaims.10.6.6

Vaishali Mishra Post Graduate Scholar, Department of Prasuti Tantra, Faculty of Ayurveda, IMS, BHU, Varanasi, India
Vishwesh B.N Professor and Head, Department of Prasuti Tantra, Faculty of Ayurveda, IMS, BHU, Varanasi, India.
Ankit Lakra Post Graduate Scholar, Department of Kaumarbhritya/Balroga, Faculty of Ayurveda, IMS, BHU, Varanasi, India. https://orcid.org/0009-0004-0712-8709

DOI: https://doi.org/10.21760/jaims.10.6.6

Keywords: Asanadi Niruha Basti, Kanashatahwadi Kashaya, Basti, Niruha Basti, Yoga Basti, Polycystic Ovarian Disease

Abstract

Polycystic ovarian syndrome is a heterogeneous, multisystem endocrinopathy in women of reproductive age with the ovarian expression of various metabolic disturbances and a wide spectrum of clinical features such as obesity, menstrual abnormalities, and Hyperandrogenism. This disease was described by and named as Stein-Leventhal syndrome in 1935. This condition is fairly common affecting 5%-15% of adolescent girls.^[1] Materials and Methods: In this study, (n=45) eligible patients were selected randomly for this study on the basis of inclusion and exclusion criteria. All selected patients were treated with Kanashatahwdi Kashaya/decoction orally for 3 months along with one cycle of Yoga Basti. Asanadi Niruha Basti and Murchhita Tila-Taila Matra Basti). Result: After the treatment, some patients experienced only symptomatic improvements. Out of a total maximum patients had only mild improvement in symptoms, out of (n=45) only 4 Patients had no improvement, (n=4) had moderate improvement, and another (n=4) had marked improvement. Conclusion: Application of Basti therapy i.e., Asanadi Niruha Basti with oral administration of Kanashatahwadi Kashaya had a beneficial effect on Polycystic ovarian syndrome.

Downloads

Download data is not yet available.

References

Howkins & Bourne. Shaw's Textbook of Gynecology. 16th ed. New Delhi: Reed Elsevier India Pvt Ltd; 2015. p.314–318. eBook ISBN: 978-81-312-3872-1.

Deans R. Polycystic ovary syndrome in adolescence. Med Sci. 2019;7:101. doi:10.3390/medsci7100101.

Witchel SF, Oberfield SE, Peña AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc. 2019;3:1545–73. doi:10.1210/js.2019-00078.

Office on Women’s Health. Polycystic Ovary Syndrome [Internet]. [Accessed 2021 Sep 22]. Available from: https://www.womenshealth.gov/a-z-topics/polycystic-ovary-syndrome

Carmina E, Dewallly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W. The Androgen Excess and PCOS Society criteria for polycystic ovarian syndrome: the complete task force report. Fertil Steril. 2009;91:456–88.

Zaveri M, Khandhar A, Patel S, Patel A. Chemistry and pharmacology of Piper longum L. Int J Pharm Sci Rev Res. 2010;5(1):Article-010.

Pereira DJ, Tharannum S. Pharmacological potential of volatile oil and extract of Anethum sowa L.: a review. Res J Agric Sci. 2021;13(2). ISSN: 0976-1675.

Shende A, Joshi S, Koli PG. Evaluation of effects of Caesalpinia crista on letrozole-induced models of PCOS. Cureus. 2023;15:e34215. doi:10.7759/cureus.34215. PMID: 36843780; PMCID: PMC9957572.

Ionescu OM, Frincu F, Mehedintu A, et al. Berberine—a promising therapeutic approach to PCOS in infertile/pregnant women. Life (Basel). 2023 Jan 2;13(1):125. doi:10.3390/life13010125. PMID: 36676074; PMCID: PMC9864590.

Wu WH, Kang YP, Wang NH, Jou HJ, Wang TA. Sesame ingestion affects sex hormones, antioxidant status, and blood lipids in postmenopausal women. J Nutr. 2006;136(5):1270–5. doi:10.1093/jn/136.5.1270. PMID: 16614415.

Jafari F, Khalilzadeh S, Nejatbakhsh F, Maziar M. Therapeutic effects of garlic (Allium sativum) on female reproductive system: a systematic review. Heliyon. 2023;9:e22555. doi:10.1016/j.heliyon.2023.e22555. PMID: 38076037; PMCID: PMC10709373.

Raj DR, Merlin NJ, Dharan SS. Hinguvachadi Choornam—an in silico approach to confirm therapeutic efficacy towards PCOS. Res J Pharm Technol. 2021;14(1):231–4. doi:10.5958/0974-360X.2021.00040.8.

Hugar AL, Kanjikar AP, Londonkar RL. Reproductive effects of Pterocarpus marsupium methanolic extract on testosterone propionate-induced PCOS in female rats. Recent Pat Endocr Metab Immune Drug Discov. 2017;11:39–43. doi:10.2174/1871530317666170912153934. PMID: 28901866.

Zhang J, Arshad K, Siddique R, et al. Rubia cordifolia pharmacological potential against letrozole-induced PCOS in rats: In vitro, in vivo and mechanistic approach. Heliyon. 2024;10(2):e34298. doi:10.1016/j.heliyon.2024.e34298.

Sharma M, Ashiya, Dei LP. Ayurvedic management of hyperprolactinemia associated with PCOS: a case report. Int J Ayurvedic Pharm Chem. 2021;14(1). Available from: www.ijapc.com

Saiyed A, Jahan N, Makbul SAA, et al. Effect of combination of Withania somnifera and Tribulus terrestris on letrozole-induced PCOS in rats. Integr Med Res. 2016;5(4):293–300. doi:10.1016/j.imr.2016.10.002.

Siriwardene SAD, Karunathilaka LPA, Kodituwakku ND, Karunarathne YAUD. Clinical efficacy of Ayurveda treatment regimen on subfertility with PCOS. Ayu. 2010;31(1):24–7. doi:10.4103/0974-8520.68203. PMID: 22131680; PMCID: PMC3215317.

Gupte PA, Khade KN, Wagh GN, et al. Effect of combination of Curcuma longa with Emblica officinalis in PCOS: exploratory clinical study. J Diabetol. 2023;14(3):126–34. doi:10.4103/jod.jod_17_23.

Dawane JS, Pandit V, Khade KS, et al. Efficacy of herbal formulation Nisamalaki in animal model of PCOS. Ancient Sci Life. 2017;37:86–93.